Your browser doesn't support javascript.
loading
Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.
Senger, Tilo; Schädlich, Lysann; Textor, Sonja; Klein, Corinna; Michael, Kristina M; Buck, Christopher B; Gissmann, Lutz.
Afiliación
  • Senger T; Department of Genome Modifications and Carcinogenesis, German Cancer Research Center, D-69120 Heidelberg, Germany. t.senger@dkfz-heidelberg.de
Vaccine ; 28(6): 1583-93, 2010 Feb 10.
Article en En | MEDLINE | ID: mdl-20003923
ABSTRACT
The potential as prophylactic vaccines of L1-based particles from cutaneous genus alpha human papillomavirus (HPV) types has not been assessed so far. However, there is a high medical need for such vaccines since HPV-induced skin warts represent a major burden for children and for immunocompromised adults, such as organ transplant recipients. In this study, we have examined the immunogenicity of capsomeres and virus-like particles (VLPs) from HPV types 2, 27, and 57, the most frequent causative agents of skin warts. Immunization of mice induced immune responses resembling those observed upon vaccination with HPV 16 L1-based antigens. The antibody responses were cross-reactive but type-restricted in their neutralizing capacities. Application of adjuvant led to an enhanced potential to neutralize the respective immunogen type but did not improve cross-neutralization. Vaccination with capsomeres and VLPs from all four analyzed HPV types induced robust IFNgamma-associated T-cell activation. Immunization with mixed VLPs from HPV types 2, 27, and 57 triggered an antibody response similar to that after single-type immunization and capable of efficiently neutralizing all three types. Our results imply that vaccination with combinations of VLPs from cutaneous HPV types constitutes a promising strategy to prevent HPV-induced skin lesions.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Verrugas / Proteínas Oncogénicas Virales / Cápside / Enfermedades Cutáneas Virales / Virosomas / Proteínas de la Cápside / Alphapapillomavirus / Vacunas contra Papillomavirus Límite: Animals Idioma: En Revista: Vaccine Año: 2010 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Verrugas / Proteínas Oncogénicas Virales / Cápside / Enfermedades Cutáneas Virales / Virosomas / Proteínas de la Cápside / Alphapapillomavirus / Vacunas contra Papillomavirus Límite: Animals Idioma: En Revista: Vaccine Año: 2010 Tipo del documento: Article País de afiliación: Alemania